IDEXX Laboratories (IDXX) analyst forecast and price target
Analyst forecast
Consensus of 17 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $710.00 from $800.00 | Aug 11, 2026 |
| Citigroup | Maintained | Neutral | $670.00 from $650.00 | Aug 5, 2026 |
| UBS | Maintained | Neutral | $670.00 from $620.00 | Aug 5, 2026 |
| UBS | Maintained | Neutral | $620.00 from $640.00 | Jul 27, 2026 |
| UBS | Maintained | Neutral | $640.00 from $730.00 | Apr 28, 2026 |
| Citigroup | Initiated Coverage | Neutral | $650.00 | Apr 15, 2026 |
| Stifel | Maintained | Buy | $675.00 from $775.00 | Mar 31, 2026 |
| Piper Sandler | Maintained | Neutral | $750.00 from $775.00 | Feb 9, 2026 |
| Barclays | Maintained | Overweight | $800.00 from $850.00 | Feb 5, 2026 |
| BTIG | Maintained | Buy | $800.00 from $830.00 | Feb 3, 2026 |
| UBS | Maintained | Neutral | $730.00 from $750.00 | Feb 3, 2026 |
| Barclays | Initiated Coverage | Overweight | $850.00 | Dec 9, 2025 |
| BTIG | Maintained | Buy | $830.00 from $785.00 | Nov 4, 2025 |
| JP Morgan | Maintained | Overweight | $775.00 from $675.00 | Nov 4, 2025 |
| UBS | Maintained | Neutral | $750.00 from $710.00 | Nov 4, 2025 |
| Morgan Stanley | Maintained | Overweight | $805.00 from $765.00 | Nov 4, 2025 |
| Stifel | Upgraded | Hold → Buy | $700.00 from $640.00 | Oct 31, 2025 |
| UBS | Initiated Coverage | Neutral | $720.00 | Oct 1, 2025 |
| Morgan Stanley | Maintained | Overweight | $765.00 from $722.00 | Aug 15, 2025 |
| Piper Sandler | Maintained | Neutral | $700.00 from $510.00 | Aug 11, 2025 |
Frequently asked questions
What is the price target for IDXX stock?
The average 12-month analyst price target for IDEXX Laboratories (IDXX) is $683.33, with a high estimate of $710.00 and a low of $670.00, across 3 analysts.
Is IDXX a buy, sell, or hold?
Analysts covering IDEXX Laboratories currently average a Buy rating: 9 buy, 7 hold and 1 sell, from 17 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for IDXX?
The average price target of $683.33 implies 22.40% upside from the last price of $558.30.
What is the latest analyst rating on IDXX?
On Aug 11, 2026, Barclays maintained IDEXX Laboratories at Overweight with a price target of $710.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.